Phosphoaziridine compounds useful for treatment of tumors

Details Phosphoaziridine compounds useful for treatment of tumors Phosphoaziridine compounds useful for treatment of tumors

1982-04-12

1986-10-14

Daus, Donald G.

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

514 83, 548956, C07D40302, C07D40314, A61K 31395

Patent

active

046173986

ABSTRACT:
Novel phosphoaziridines of the formula: ##STR1## wherein Z is oxygen or sulfur, R.sub.1 is independently at each occurrence H or --CH.sub.3, R.sub.2 is independently at each occurrence --CH.sub.3 or nitrophenyl R.sub.5 ; R.sub.3 is --NHR.sub.4, --OR.sub.4, --SR.sub.4 or ##STR2## where R.sub.4 is a radical containing up to 30 atoms including at least one amine, ester, ether, alkyl, substituted alkyl, hydrogen, phenyl, substituted phenyl, carbamate, heterocyclic ring or R.sub.5 group; provided that, when R.sub.4 contains and R.sub.5 group, R.sub.4 has an alkyl group between the phosphorous and the R.sub.5 group; and R.sub.5 is a radical containing and electron affinic group comprising a quinone, or a heterocyclic or phenyl ring directly connected to a radical selected from the group consisting of nitro, nitroso, sulfinyl, sulfoxine, and N-oxide; provided that the compound contains at least one R.sub.5 radical and provided that when R.sub.1 is H, the R.sub.2 group on the same ring is R.sub.5 ; and the method for using the above compounds for the treatment of tumors.

REFERENCES:
patent: 2606900 (1952-08-01), Parker et al.
patent: 3201313 (1965-08-01), Bardos et al.
patent: 3314848 (1967-04-01), Ratz et al.
patent: 3865830 (1975-02-01), Turkevich et al.
Burger ed., Medicinal Chemistry 3rd ed., Wiley-Interscience, N.Y., 1970, pp. 694-697.
Wodinsky et al., Chem. Abstracts, 92:121773n.
Wampler et al., Absence of Cross-Resistance to Alkylating Agents in Cyclophosphamide-Resistant L1210 Leukemia, Europ. J. Cancer, vol. 14, pp. 977-982, 1978.
Bardos et al., Synthesis of Potential Dual Antagonists III, Jour. of Pharmaceutical Sciences, vol. 54, No. 2, Feb., 1965.
Chmielewicz et al., Synthesis and Chemotherapeutic Effects of Ethyl Bis-(2,2-Dimethyl)-Ethylenamido Phosphate. A Preliminary Report, Jour. of Pharmaceutical Sciences, vol. 56, No. 9, Sep. 1967.
Wodinsky et al., Combined Therapy with an Aziridine Derivative NSC 200724 (AB182) and Radiation on an Experimental Leukemia. Int. J. Radiation Oncology Biol. Phys., vol. 4, pp. 1677-1680, 1979.
Hsiao et al., Synthesis of New Bis(1-Aziridinyl) Phosphinate Alkylating Agents Containing O-Phenyl N-Phenylcarbamate Side Chains, Jour. of Med. Chem, vol. 16, p. 391, 1973.
Lalka et al., Reactions of 2,2-Dimethyl-Aziridine-Type Alkylating Agents in Biological Systems I: Colorimetric Estimation and Stability in Physiological Media, Jour. of Pharmaceutical Sciences, vol. 62, No. 8, Aug., 1973.
Bardos et al., Synthesis of Potential Dual Antagonists IV, Jour. of Pharmaceutical Sciences, Vol. 54, No. 3, Mar., 1965.
Hsiao et al., Synthesis of Bis(Aziridinyl)Phosphinyl-N-Hydroxyurethane Derivatives as Antineoplastic Agents, Jour. of Medical Chemistry, vol. 18, p. 195, 1975.
Bardos et al., Combination of Chemotherapy with Dual Antagonists and Radiotherapy in the Treatment of Neoplastic Disease, Journal of Surgical Oncology 3(4); pp. 431-441, 1971.
Bardos et al., Structure-Activity Relationships of Alkylating Agents in Cancer Chemotherapy, Annals of The New York Academy of Sciences, vol. 163, Article 2, pp. 1006-1025, Oct. 3, 1969.
Chmielwicz et al., Alternations of Some Macromolecular and Biochemical Properties of Calf Thymus DNA Caused by "Dual Antagonists" and Nitrogen Mustard, Cancer Research, 27, pp. 1248-1257, Jul. 1967.
Munson et al., Preparation and Antitumor Activity of Tris(2,2-Dimethyl-1-Aziridinyl)Phosphine Oxide (TEPA-132), Cancer Chemotherapy Reports, vol. 51, No. 5. pp. 253-259, Sep. 1967.
Bardos et al., Effects of Ring-C-Methyl Substituents on the Chemical and Biological Activities of Ethylenimine Type Alkylating Agents Int. Congress of Chemotherapy, Jun. 1967.
Bardos, Antimetabolites, Molecular Design and Mode of Action, Topics in Current Chemistry, vol. 52, pp. 90 and 91 only, 1974.
Lalka et al., Cyclophosphamide, 2,2-Dimethyl-Aziridines and Other Alkylating Agents as Inhibitors of Serum Cholinesterase, Biochemical Pharmacology, vol. 24, pp. 455-462, 1975.
Lalka et al., Reactions of 2,2-Dimethyl-Aziridine-Type Alkylating Agents in Biological Systems II: Comparative Pharmacokinetics in DOGS, Jour., of Pharmaceutical Sciences, vol. 64, No. 2, Feb., 1975.
Bardos et al., Chemical Mechanism of the Radiation Potentiating Effects of 2,2-Dimethylaziridine-Type Antitumor Agents, Int. J. Radiation Oncology Biol. Phys., vol. 4, pp. 1653-1656, 1979.
Wampler et al., Radiation Potentiating Effect of Ethyl Bis(2,2-Dimethyl-1-Aziridinyl) Phosphinate (AB-163), Int. J. Radiation Oncology Biol. Phys., vol. 5, pp. 1681-1683, 1979.
Hsiao et al., Synthesis of 5'-Thymidinyl Bis(1-Aziridinyl)Phosphinates as Antineoplastic Agents, Jour of Med. Chemistry, vol. 24, pp. 887-889, 1981.
Zhdanov et al., Biologically Active Stable Radicals; XV.sup.1. Spinlabeled Alkyl Carbamate-N-Phosphonic Acid Aziridides, "Synthesis" pp. 269-271, 1979.
Konieczny et al., Methods for the Preparation of Spin-Labeled Phosphorus Compounds and Applications of Some of Them to Phosphorylative Spin-Labeling, "Synthesis", Sep. 1981.
Kimler et al., Development and Testing of New Hypoxic Cell Radiosensitizers, Radiology, vol. 33, pp. 515-517, 1979.

Affiliated with

Also associated with

Rating

Phosphoaziridine compounds useful for treatment of tumors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Phosphoaziridine compounds useful for treatment of tumors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phosphoaziridine compounds useful for treatment of tumors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1341206